<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Diagn Pathol</journal-id>
      <journal-id journal-id-type="iso-abbrev">Diagn Pathol</journal-id>
      <journal-title-group>
        <journal-title>Diagnostic Pathology</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1746-1596</issn>
      <publisher>
        <publisher-name>BioMed Central</publisher-name>
        <publisher-loc>London</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">27846861</article-id>
      <article-id pub-id-type="pmc">5111215</article-id>
      <article-id pub-id-type="publisher-id">586</article-id>
      <article-id pub-id-type="doi">10.1186/s13000-016-0586-z</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Intraosseous inflammatory myofibroblastic tumor of the mandible with a novel <italic>ATIC-ALK</italic> fusion mutation: a case report</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Tateishi</surname>
            <given-names>Yoko</given-names>
          </name>
          <address>
            <phone>+81-45-787-2583</phone>
            <email>ytateish@yokohama-cu.ac.jp</email>
          </address>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Okudela</surname>
            <given-names>Koji</given-names>
          </name>
          <address>
            <email>kojixok@yokohama-cu.ac.jp</email>
          </address>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kawai</surname>
            <given-names>Shigeo</given-names>
          </name>
          <address>
            <email>skawai4836@yahoo.co.jp</email>
          </address>
          <xref ref-type="aff" rid="Aff2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Suzuki</surname>
            <given-names>Takehisa</given-names>
          </name>
          <address>
            <email>t380615@yokohama-cu.ac.jp</email>
          </address>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Umeda</surname>
            <given-names>Shigeaki</given-names>
          </name>
          <address>
            <email>umeda@yokohama-cu.ac.jp</email>
          </address>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Matsumura</surname>
            <given-names>Mai</given-names>
          </name>
          <address>
            <email>yoshima0112@yahoo.co.jp</email>
          </address>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kioi</surname>
            <given-names>Mitomu</given-names>
          </name>
          <address>
            <email>kioi@yokohama-cu.ac.jp</email>
          </address>
          <xref ref-type="aff" rid="Aff3">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Ohashi</surname>
            <given-names>Kenichi</given-names>
          </name>
          <address>
            <email>Ohashi@yokohama-cu.ac.jp</email>
          </address>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <aff id="Aff1"><label>1</label>Department of Pathology, Yokohama City University Graduate School of Medicine, Yokohama, Japan </aff>
        <aff id="Aff2"><label>2</label>Department of Pathology, Japanese Red-Cross Musashino Hospital, Tokyo, Japan </aff>
        <aff id="Aff3"><label>3</label>Department of Oral and Maxillofacial Surgery, Yokohama City University Graduate School of Medicine, Yokohama, Japan </aff>
      </contrib-group>
      <pub-date pub-type="epub">
        <day>15</day>
        <month>11</month>
        <year>2016</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>15</day>
        <month>11</month>
        <year>2016</year>
      </pub-date>
      <pub-date pub-type="collection">
        <year>2016</year>
      </pub-date>
      <volume>11</volume>
      <elocation-id>132</elocation-id>
      <history>
        <date date-type="received">
          <day>12</day>
          <month>2</month>
          <year>2016</year>
        </date>
        <date date-type="accepted">
          <day>9</day>
          <month>11</month>
          <year>2016</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; The Author(s). 2016</copyright-statement>
        <license license-type="OpenAccess">
          <license-p>
<bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p>
        </license>
      </permissions>
      <abstract id="Abs1">
        <sec>
          <title>Background</title>
          <p>Inflammatory myofibroblastic tumor (IMT) is a rare low-grade malignant neoplasm with a predilection for children and young adults, and typically arises in the lung, abdominopelvic region, and retroperitoneum. IMTs in the maxillofacial region are extreme rare. Approximately 50% of IMT harbor rearrangements of the anaplastic lymphoma kinase (<italic>ALK</italic>) gene at 2p23 with various fusion partners.</p>
        </sec>
        <sec>
          <title>Case presentation</title>
          <p>We herein report a case of intraosseous IMT of the mandible with a novel <italic>ATIC-ALK</italic> fusion. Tooth 43 did not erupt after the loss of tooth 83 in an 11-year-old girl with no previous history of trauma. Panoramic tomography showed a unilocular radiolucent lesion in the right anterior mandible resorbing the root of tooth 42 and the medial side of the root of tooth 44. Computed tomography revealed a well- circumscribed 3-cm osteolytic lesion of the right anterior mandible eroding the buccal cortical plate. The entire lesion was curetted out. A histopathological examination revealed the proliferation of plump spindle cells with a storiform architecture and lymphocytes scattered around spindle cells. The spindle cells showed diffuse cytoplasmic staining for ALK by immunohistochemistry. A fluorescence <italic>in situ</italic> hybridization analysis revealed the translocation of a part of the <italic>ALK</italic> gene locus at chromosome 2p23. A rapid amplification of cDNA ends analysis confirmed the rearrangement of <italic>ALK</italic> and identified <italic>ATIC</italic> as a partner of this <italic>ALK</italic> fusion mutant.</p>
        </sec>
        <sec>
          <title>Conclusion</title>
          <p>To the best of our knowledge, this is the first case of intraosseous IMT of the mandible with a novel <italic>ATIC-ALK</italic> fusion. We also herein reviewed similar tumors reported in the literature.</p>
        </sec>
      </abstract>
      <kwd-group xml:lang="en">
        <title>Keywords</title>
        <kwd>Inflammatory myofibroblastic tumor</kwd>
        <kwd>Mandible</kwd>
        <kwd>Anaplastic lymphoma kinase gene</kwd>
        <kwd><italic>ATIC-ALK</italic> fusion</kwd>
        <kwd>Fluorescence in situ hybridization</kwd>
        <kwd>5&#x2032; rapid amplification of cDNA ends</kwd>
        <kwd>RT-PCR</kwd>
      </kwd-group>
      <custom-meta-group>
        <custom-meta>
          <meta-name>issue-copyright-statement</meta-name>
          <meta-value>&#xA9; The Author(s) 2016</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <sec id="Sec1" sec-type="introduction">
      <title>Background</title>
      <p>Inflammatory myofibroblastic tumors (IMTs) are more frequent in children and young adults, and typically arise in the lung, abdominopelvic region, and retroperitoneum [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR2">2</xref>]. Unusual sites of involvement include the head and neck, genitourinary tract, heart, extremities, and central nervous system [<xref ref-type="bibr" rid="CR2">2</xref>]. While these tumors are rare in the head and neck, they are even more uncommon in the mandible [<xref ref-type="bibr" rid="CR3">3</xref>].</p>
      <p>IMTs are mesenchymal neoplasms of intermediate malignant potential and histologically characterized by the proliferation of fibroblasts and myofibroblasts admixed with lymphocytes, plasma cells, eosinophils, and histiocytes [<xref ref-type="bibr" rid="CR1">1</xref>]. The histological features of IMTs are often diagnostic, particularly through anaplastic lymphoma kinase (ALK) staining. The <italic>ALK</italic> gene has been implicated in the pathogenesis of IMTs, which supports the neoplastic origin of these tumors. Approximately 50% of IMTs harbor rearrangements in the <italic>ALK</italic> gene at 2p23 [<xref ref-type="bibr" rid="CR4">4</xref>]. However, to the best of our knowledge, an <italic>ALK</italic> fusion mutation has not yet been demonstrated in IMTs in the jawbone.</p>
      <p>We herein report a case of an intraosseous IMT in the mandible including a novel <italic>ATIC-ALK</italic> fusion mutation.</p>
    </sec>
    <sec id="Sec2">
      <title>Case presentation</title>
      <sec id="Sec3">
        <title>Clinical features</title>
        <p>An 11-year-old girl presented with the delayed eruption of tooth 43 (two digit tooth notation system of the FDI) and mental nerve palsy. She had no history of trauma. An intraoral examination revealed that tooth 43 had not erupted after the loss of tooth 83 and the gingiva and alveolar mucosa of the right mandible were normal. Panoramic tomography showed a unilocular radiolucent lesion in the right anterior mandible resorbing the root of tooth 42 and the medial side of the root of tooth 44 (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1a</xref>). Tooth 43 was not impacted in the mandibular bone. Computed tomography showed a well-circumscribed non-expansile 3-cm osteolytic lesion in the right anterior mandible that eroded the buccal cortical plate and resorbed the root of tooth 42 and the medial side of the root of tooth 44 (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1b</xref>). Root resorption and cortical plate erosion suggested a locally aggressive tumor. The tumor lesion was entirely curetted out. No recurrence was detected in 18&#xA0;months of follow-up.<fig id="Fig1"><label>Fig. 1</label><caption><p>
<bold>a</bold> Panoramic tomography showed the resorption of the root of tooth 42 and medial side of the root of tooth 44 (<italic>arrow heads</italic>). <bold>b</bold> Computed tomography revealed a well- circumscribed 3-cm osteolytic lesion in the right mandible that eroded the buccal cortical plate and resorbed the roots of tooth 42 and tooth 44 (<italic>arrows</italic>)</p></caption><graphic xlink:href="13000_2016_586_Fig1_HTML" id="MO1"/></fig>
</p>
      </sec>
      <sec id="Sec4">
        <title>Histopathological features and differential diagnosis</title>
        <p>A histopathological investigation revealed plump spindle cell proliferation with a storiform architecture and lymphocytes scattered around the spindle cells (Fig.&#xA0;<xref rid="Fig2" ref-type="fig">2a</xref>, <xref rid="Fig2" ref-type="fig">b</xref>). The background stroma included a focal myxoid matrix. These spindle cells had ovoid nuclei with a pale eosinophilic cytoplasm, suggesting a myofibroblastic, myoepithelial, or fibroblastic lineage. Small islands of an odontogenic epithelium were detected. No mitosis or necrosis was observed. The histomorphological findings suggested that spindle cells were of a myofibroblastic, myoepithelial, or fibroblastic lineage. Small islands of an odontogenic epithelium suggested that this tumor was an odontogenic tumor. High-grade malignant tumors were excluded because neither mitosis nor necrosis was observed. Differential diagnoses included myofibroma, myoepithelioma, an odontogenic tumor, solitary fibrous tumor, giant cell granuloma, and IMT.<fig id="Fig2"><label>Fig. 2</label><caption><p>Hematoxylin and eosin staining (<bold>a</bold>, <bold>b</bold>) and immunohistochemical staining (<bold>c</bold>, <bold>d</bold>). <bold>a</bold> The proliferation of plump spindle cells with a storiform architecture with scattered lymphocytes. Epithelioid components with an appearance suggestive of odontogenic epithelioid cells were detected. <bold>b</bold> Spindle cells contained ovoid nuclei with a pale eosinophilic cytoplasm. <bold>c</bold> Spindle cells were positive for SMA. <bold>d</bold> Spindle cells were positive for ALK</p></caption><graphic xlink:href="13000_2016_586_Fig2_HTML" id="MO2"/></fig>
</p>
      </sec>
      <sec id="Sec5">
        <title>Immunohistochemical findings</title>
        <p>Immunohistochemical staining revealed that spindle cells were positive for &#x3B1;-smooth muscle actin (SMA) (Fig.&#xA0;<xref rid="Fig2" ref-type="fig">2c</xref>), ALK (Fig.&#xA0;<xref rid="Fig2" ref-type="fig">2d</xref>), CD10, and glial fibrillary acidic protein (GFAP), and negative for cytokeratin AE1/AE3, S100 proteins, and p63. The Ki67 labeling index was 3%.</p>
      </sec>
      <sec id="Sec6">
        <title>Molecular pathological findings</title>
        <sec id="Sec7">
          <title>FISH</title>
          <p>A fluorescence <italic>in situ</italic> hybridization (FISH) <italic>(ALK)</italic> analysis was performed on a formalin-fixed paraffin-embedded (FFPE) tissue block. Rearrangements in the <italic>ALK</italic> gene at chromosome band 2p23 were detected by FISH utilizing a Vysis ALK break apart probe (Abott Molecular). The FISH analysis revealed the translocation of a part of the <italic>ALK</italic> gene locus (Fig.&#xA0;<xref rid="Fig3" ref-type="fig">3a</xref>).<fig id="Fig3"><label>Fig. 3</label><caption><p>
<bold>a</bold> FISH assay with a break apart probe for the <italic>ALK</italic> gene shows one intact yellow signal and one separated red and green signal per nucleus in tumor cells, indicating the presence of a rearrangement in the <italic>ALK</italic> gene. <bold>b</bold> The 5&#x2032; RACE analysis identified <italic>ATIC</italic> as a fusion partner. The sequence of the second round PCR product covering the fusion point (arrow) is shown. <bold>c</bold> The results of the RT-PCR analysis for <italic>ATIC-ALK</italic> are shown. PT: Present tumor, UT: Unrelated tumor (lung tumor), DW: Distilled Water, GAPDH: glyceraldehydes-3-phosphate dehydrogenase</p></caption><graphic xlink:href="13000_2016_586_Fig3_HTML" id="MO3"/></fig>
</p>
        </sec>
        <sec id="Sec8">
          <title>RACE</title>
          <p>Total RNA was extracted from frozen tissue using an RNeasy mini kit (Qiagen) according to the manufacturer&#x2019;s instructions. In order to obtain cDNA fragments corresponding to a novel <italic>ALK</italic> fusion gene, a rapid amplification of cDNA ends (RACE) analysis was performed using the 5&#x2032;-full RACE core set (TaKaRa Bio) according to the manufacturer&#x2019;s instructions. First-strand cDNA synthesis was performed with a 5&#x2032; end-phosphorylated RT primer (5&#x2032;-ATCTGGGCCTTGTATTTATCACTC). The primer set used for the first round of PCR was the A1 primer (5&#x2032;-ACTTCCTGGTTGCTTTTGCTGGGGTAT) [<xref ref-type="bibr" rid="CR5">5</xref>] and S1 primer (5&#x2032;-AGAAGGAGCCACACGACAGGGGTAA). The primer set used for the second round of PCR was the S2 primer (5&#x2032;-CTCCTTCACAAACCAGAGACCAA) and A2 primer (5&#x2032;-TTCAGGCAGCGTCTTCACAG). The second round PCR product covering the break point was sub-cloned into a pT7Blue plasmid vector (TaKaRa Bio). The DNA sequence was analyzed using universal primers (M13M4 primer or T7 promoter primer) and the Big-dye terminator ver3.1 kit (Applied Biosystems). A RACE analysis confirmed a rearrangement in ALK and identified ATIC (NM_004044) as a partner of this ALK fusion mutant (Fig.&#xA0;<xref rid="Fig3" ref-type="fig">3b</xref>).</p>
        </sec>
        <sec id="Sec9">
          <title>RT-PCR</title>
          <p>First-strand cDNA was synthesized from total RNA using the SuperScript First-Strand Synthesis System (Invitrogen) according to the manufacturer&#x2019;s instructions. RT-PCR was used to confirm the presence of the <italic>AITC-ALK</italic> fusion gene in this case. The primer set used was as follows: forward (5&#x2032;-CCAAGCTTCCCATCACAGTGTACC) and reverse (5&#x2032;-GAGGTCTTGCCAGCAAAGCAGTAG). RT-PCR was used to confirm the presence of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) in this case. The primer set used was as follows: forward (5&#x2032;-TGGAGTCCACTGGCGTCTTC) and reverse (5&#x2032;-ATGACGAACATGGGGGCATCAG). A RT-PCR analysis confirmed the <italic>ATIC-ALK</italic> fusion in tumor cells (Fig.&#xA0;<xref rid="Fig3" ref-type="fig">3c</xref>).</p>
          <p>Based on these results, the final diagnosis was IMT.</p>
        </sec>
      </sec>
    </sec>
    <sec id="Sec10">
      <title>Discussion</title>
      <p>We herein presented the first case of IMT with an <italic>ATIC-ALK</italic> fusion mutation primarily in the maxillofacial region. IMTs are rare mesenchymal tumors. Different terms have been applied to these lesions, namely, xanthogranuloma, plasma cell granuloma, inflammatory pseudotumor (IPT), and inflammatory myofibroblastic sarcoma [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR6">6</xref>, <xref ref-type="bibr" rid="CR7">7</xref>]. The diverse nomenclature is descriptive and reflects the uncertainty regarding the true biological nature of these lesions. In 2013, the World Health Organization classification of soft tissue and bone defined IMT as a distinctive neoplasm composed of myofibroblastic and fibroblastic spindle cells accompanied by an inflammatory infiltrate of plasma cells, lymphocytes, and/or eosinophils [<xref ref-type="bibr" rid="CR1">1</xref>]. The expression of ALK proteins is detected by anti-ALK immunohistochemistry in approximately 50% of IMT cases. ALK protein expression has been shown to reliably correlate with <italic>ALK</italic> gene rearrangements [<xref ref-type="bibr" rid="CR8">8</xref>]. These lines of evidence support ALK-positive IMT being a distinct neoplastic entity. ALK immunostaining is an aid in the pathological diagnosis of IMTs, as well as in the differentiation of IMTs from other spindle cell neoplasms that fall within the broad category of IPTs. We reviewed 12 cases of intraosseous tumors of the mandible with similar histological features in the literature (Table&#xA0;<xref rid="Tab1" ref-type="table">1</xref>) [<xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR9">9</xref>&#x2013;<xref ref-type="bibr" rid="CR19">19</xref>]. Six cases were diagnosed as IPTs and 6 as IMTs in the mandible. ALK-positive IMT/IPT in the mandible was initially reported in 2005 [<xref ref-type="bibr" rid="CR10">10</xref>] and only 4 cases including ours have been reported since then [<xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR19">19</xref>].<table-wrap id="Tab1"><label>Table 1</label><caption><p>Clinicopathological features of IMTs in the mandible described in the present and previous reports</p></caption><table frame="hsides" rules="groups"><thead><tr><th>No.</th><th>Authors (yr.)</th><th>Age (yr.)</th><th>Sex</th><th>Diagnosis</th><th>ALK-IHC</th><th>FISH</th><th>RT-PCR</th></tr></thead><tbody><tr><td>1</td><td>Zegarelli (1974) [<xref ref-type="bibr" rid="CR7">7</xref>]</td><td>56</td><td>F</td><td>Granuloma (?IPT)</td><td>NA</td><td>NA</td><td>NA</td></tr><tr><td>2</td><td>Inui (1993) [<xref ref-type="bibr" rid="CR9">9</xref>]</td><td>63</td><td>M</td><td>IPT</td><td>NA</td><td>NA</td><td>NA</td></tr><tr><td>3</td><td>Brooks (2005) [<xref ref-type="bibr" rid="CR10">10</xref>]</td><td>82</td><td>F</td><td>IMT</td><td>positive</td><td>NA</td><td>NA</td></tr><tr><td>4</td><td>Poh (2005) [<xref ref-type="bibr" rid="CR11">11</xref>]</td><td>42</td><td>F</td><td>IMT</td><td>positive</td><td>NA</td><td>NA</td></tr><tr><td>5</td><td>Oh (2008) [<xref ref-type="bibr" rid="CR12">12</xref>]</td><td>20</td><td>F</td><td>IPT</td><td>NA</td><td>NA</td><td>NA</td></tr><tr><td>6</td><td>Johann (2008) [<xref ref-type="bibr" rid="CR13">13</xref>]</td><td>33</td><td>M</td><td>IPT</td><td>NA</td><td>NA</td><td>NA</td></tr><tr><td>7</td><td>Satomi (2010) [<xref ref-type="bibr" rid="CR14">14</xref>]</td><td>14</td><td>F</td><td>IMT</td><td>negative</td><td>NA</td><td>NA</td></tr><tr><td>8</td><td>Date (2010) [<xref ref-type="bibr" rid="CR15">15</xref>]</td><td>70</td><td>M</td><td>IPT</td><td>negative</td><td>NA</td><td>NA</td></tr><tr><td>9</td><td>Sasagawa (2011) [<xref ref-type="bibr" rid="CR16">16</xref>]</td><td>60</td><td>M</td><td>IMT</td><td>NA</td><td>NA</td><td>NA</td></tr><tr><td>10</td><td>Gawande (2012) [<xref ref-type="bibr" rid="CR17">17</xref>]</td><td>20</td><td>M</td><td>IPT</td><td>NA</td><td>NA</td><td>NA</td></tr><tr><td>11</td><td>Sah (2013) [<xref ref-type="bibr" rid="CR18">18</xref>]</td><td>30</td><td>M</td><td>IMT</td><td>negative</td><td>NA</td><td>NA</td></tr><tr><td>12</td><td>Stringer (2014) [<xref ref-type="bibr" rid="CR19">19</xref>]</td><td>16</td><td>M</td><td>IMT</td><td>positive</td><td>NA</td><td>NA</td></tr><tr><td>13</td><td>Present case</td><td>11</td><td>F</td><td>IMT</td><td>positive</td><td>positive</td><td>
<italic>ATIC-ALK</italic>
</td></tr></tbody></table><table-wrap-foot><p>
<italic>ALK</italic> anaplastic lymphoma kinase, IHC immunohistochemistry, FISH Fluorescene in situ hybridization, F female, M male, IPT Inflammatory pseudotumor, IMT Inflammatory myofibroblastic tumor, NA data not available</p></table-wrap-foot></table-wrap>
</p>
      <p>Thus, IMT may very rarely occur in the mandible. Otherwise, IMT may often be misdiagnosed because difficulties are associated with its histological differentiation from other spindle cell neoplasms and reactive lesions. Differential diagnoses include posttraumatic spindle cell nodules, giant cell granuloma, myofibroma, myoepithelioma, ameloblastic fibroma, odontogenic myxofibroma, IMT, a solitary fibrous tumor, low-grade myofibroblastic sarcoma, myofibrosarcoma, leiomyosarcoma, and spindle cell carcinoma. The immunohistochemical expression of the ALK protein is a very important hallmark for differentiating IMT from those described above. Therefore, if spindle cell lesions are detected in the jawbone, IMT must be included in the differential diagnosis and an immunohistochemical examination of ALK protein expression is needed.</p>
      <p>The present tumor was confirmed to have the <italic>ATIC-ALK</italic> fusion mutation. Different <italic>ALK</italic> fusion partners, including <italic>TPM3</italic>, <italic>TPM4</italic>, <italic>CLTC</italic>, <italic>CARS</italic>, <italic>RANBP2</italic>, <italic>ATIC</italic>, <italic>SEC31L1</italic>, <italic>PPFIBP1</italic>, and <italic>DCTN1</italic>, in which <italic>TPM3</italic> is the most common partner, have been identified in IMTs [<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR20">20</xref>&#x2013;<xref ref-type="bibr" rid="CR26">26</xref>]. <italic>ATIC-ALK</italic> fusion mutations are very rare, comprising approximately 1% of ALK-fusion mutations in anaplastic large cell lymphomas (ALCL) [<xref ref-type="bibr" rid="CR27">27</xref>]. The hypothetical schema of the gene fusion between <italic>ATIC</italic> and <italic>ALK</italic> is shown in Fig.&#xA0;<xref rid="Fig4" ref-type="fig">4</xref> [<xref ref-type="bibr" rid="CR28">28</xref>]. To the best of our knowledge, one case of urinary bladder IMT with the <italic>ATIC-ALK</italic> fusion mutation and one case of IMT arising from the hyoid bone in a neonate with the <italic>ATIC-ALK</italic> fusion have been reported in the literature [<xref ref-type="bibr" rid="CR23">23</xref>, <xref ref-type="bibr" rid="CR29">29</xref>]. Thus, the present case is the first IMT with the <italic>ATIC-ALK</italic> fusion mutation primarily in the mandible.<fig id="Fig4"><label>Fig. 4</label><caption><p>The hypothetical schema of the gene fusion between <italic>ALK</italic> and <italic>ATIC. ATIC</italic>-<italic>ALK</italic> fusion is generated by the pericentric inversion of chromosome 2 at the breakpoints of p23 and q35 [inv(2)(p23q35)], in which the <italic>ALK</italic> and <italic>ATIC</italic> genes are localized</p></caption><graphic xlink:href="13000_2016_586_Fig4_HTML" id="MO4"/></fig>
</p>
      <p>The management of IMTs needs to entail complete surgical resection, including postoperative reassessments for at least 10&#xA0;years [<xref ref-type="bibr" rid="CR30">30</xref>]. Although the number of IMTs in the jawbone is limited, they appear to exhibit a favorable clinical course. However, it is important to emphasize that IMTs occasionally behave in an aggressive manner. Poh et al. reported the local recurrence of an intraosseous mandibular IMT 14&#xA0;months after initial surgery [<xref ref-type="bibr" rid="CR11">11</xref>]. Sasagawa et al. described a case of multiple IMTs involving the cranium, mandible, ischium, and calcaneus [<xref ref-type="bibr" rid="CR16">16</xref>]. The ALK inhibitor, crizotinib, was recently demonstrated to be clinically beneficial for IMTs with ALK fusion mutations [<xref ref-type="bibr" rid="CR26">26</xref>, <xref ref-type="bibr" rid="CR31">31</xref>&#x2013;<xref ref-type="bibr" rid="CR33">33</xref>].</p>
    </sec>
    <sec id="Sec11">
      <title>Conclusion</title>
      <p>IMTs are rare lesions in the mandible. The general consensus is that IMTs encompass a group of heterogeneous lesions with various biological behaviors. However, a proportion of cases are genuine neoplasms with the involvement of <italic>ALK</italic> fusion mutations. The recognition of this diagnostic entity is important for selecting appropriate treatments.</p>
      <p>To the best of our knowledge, we are the first to describe IMT with the <italic>ATIC-ALK</italic> fusion mutation in the mandible.</p>
    </sec>
  </body>
  <back>
    <glossary>
      <title>Abbreviations</title>
      <def-list>
        <def-item>
          <term>IMT</term>
          <def>
            <p>Inflammatory myofibroblatic tumor</p>
          </def>
        </def-item>
        <def-item>
          <term>ALK</term>
          <def>
            <p>Anaplastic lymphoma kinase</p>
          </def>
        </def-item>
        <def-item>
          <term>FISH</term>
          <def>
            <p>Fluorescence <italic>in situ</italic> hybridization</p>
          </def>
        </def-item>
        <def-item>
          <term>RACE</term>
          <def>
            <p>Rapid amplification of cDNA ends</p>
          </def>
        </def-item>
        <def-item>
          <term>RT-PCR</term>
          <def>
            <p>Reverse transcription polymerase Chain reaction</p>
          </def>
        </def-item>
        <def-item>
          <term>IPT</term>
          <def>
            <p>Inflammatory pseudotumor</p>
          </def>
        </def-item>
      </def-list>
    </glossary>
    <ack>
      <p>We would like to sincerely thank Mr. Hideaki Mitsui for his technical support.</p>
      <sec id="FPar1">
        <title>Funding</title>
        <p>This paper was not financially supported.</p>
      </sec>
      <sec id="FPar2">
        <title>Availability of data and materials</title>
        <p>The dataset supporting the conclusions of this article is included within the article.</p>
      </sec>
      <sec id="FPar3">
        <title>Authors&#x2019; contributions</title>
        <p>YT and KO carried out the molecular genetic studies and drafted the manuscript. SK provided histological and immunohistological evaluation. TS, SU and MM carried out the molecular genetic studies. MK attended the patient and arranged the clinical examination. KO conceived of the study, and participated in its design and coordination and helped to draft the manuscript. All authors read and approved the final manuscript.</p>
      </sec>
      <sec id="FPar4">
        <title>Competing interests</title>
        <p>The authors declare that they have no competing interests.</p>
      </sec>
      <sec id="FPar5">
        <title>Consent for publication</title>
        <p>Written informed consent was obtained from the patient&#x2019;s family for the publication of this case report and any accompanying images.</p>
      </sec>
      <sec id="FPar6">
        <title>Ethics approval and consent to participate</title>
        <p>Not applicable for Case Report.</p>
      </sec>
    </ack>
    <ref-list id="Bib1">
      <title>References</title>
      <ref id="CR1">
        <label>1.</label>
        <mixed-citation publication-type="other">Coffin CM, Fletcher JA. Inflammatory myofibroblastic tumour. In Fletcher CDM, Bridge JA, Hogendoorn PCW, Mertens F eds. World Health Organization classification of tumours soft tissue andbone. Lyon: IARC Press; 2013. p. 83&#x2013;4.</mixed-citation>
      </ref>
      <ref id="CR2">
        <label>2.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Coffin</surname>
              <given-names>CM</given-names>
            </name>
            <name>
              <surname>Hornick</surname>
              <given-names>JL</given-names>
            </name>
            <name>
              <surname>Fletcher</surname>
              <given-names>CD</given-names>
            </name>
          </person-group>
          <article-title>Inflammatory myofibroblastic tumor: comparison of clinicopathologic, histologic, and immunohistochemical features including ALK expression in atypical and aggressive cases</article-title>
          <source>Am J Surg Pathol</source>
          <year>2007</year>
          <volume>31</volume>
          <issue>4</issue>
          <fpage>509</fpage>
          <lpage>20</lpage>
          <pub-id pub-id-type="doi">10.1097/01.pas.0000213393.57322.c7</pub-id>
          <pub-id pub-id-type="pmid">17414097</pub-id>
        </element-citation>
      </ref>
      <ref id="CR3">
        <label>3.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Park</surname>
              <given-names>SB</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>JH</given-names>
            </name>
            <name>
              <surname>Weon</surname>
              <given-names>YC</given-names>
            </name>
          </person-group>
          <article-title>Imaging findings of head and neck inflammatory pseudotumor</article-title>
          <source>AJR Am J Roentgenol</source>
          <year>2009</year>
          <volume>193</volume>
          <issue>4</issue>
          <fpage>1180</fpage>
          <lpage>6</lpage>
          <pub-id pub-id-type="doi">10.2214/AJR.09.2398</pub-id>
          <pub-id pub-id-type="pmid">19770345</pub-id>
        </element-citation>
      </ref>
      <ref id="CR4">
        <label>4.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cessna</surname>
              <given-names>MH</given-names>
            </name>
            <name>
              <surname>Zhou</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Sanger</surname>
              <given-names>WG</given-names>
            </name>
            <name>
              <surname>Perkins</surname>
              <given-names>SL</given-names>
            </name>
            <name>
              <surname>Tripp</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Pickering</surname>
              <given-names>D</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Expression of ALK1 and p80 in inflammatory myofibroblastic tumor and its mesenchymal mimics: a study of 135 cases</article-title>
          <source>Mod Pathol</source>
          <year>2002</year>
          <volume>15</volume>
          <issue>9</issue>
          <fpage>931</fpage>
          <lpage>8</lpage>
          <pub-id pub-id-type="doi">10.1097/01.MP.0000026615.04130.1F</pub-id>
          <pub-id pub-id-type="pmid">12218210</pub-id>
        </element-citation>
      </ref>
      <ref id="CR5">
        <label>5.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lawrence</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Perez-Atayde</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Hibbard</surname>
              <given-names>MK</given-names>
            </name>
            <name>
              <surname>Rubin</surname>
              <given-names>BP</given-names>
            </name>
            <name>
              <surname>Dal Cin</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Pinkus</surname>
              <given-names>JL</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>TPM3-ALK and TPM4-ALK oncogenes in inflammatory myofibroblastic tumors</article-title>
          <source>Am J Pathol</source>
          <year>2000</year>
          <volume>157</volume>
          <issue>2</issue>
          <fpage>377</fpage>
          <lpage>84</lpage>
          <pub-id pub-id-type="doi">10.1016/S0002-9440(10)64550-6</pub-id>
          <pub-id pub-id-type="pmid">10934142</pub-id>
        </element-citation>
      </ref>
      <ref id="CR6">
        <label>6.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rudy</surname>
              <given-names>HN</given-names>
            </name>
            <name>
              <surname>Scheingold</surname>
              <given-names>SS</given-names>
            </name>
          </person-group>
          <article-title>Solitary xanthogranuloma of the mandible; report of a case</article-title>
          <source>Oral Surg Oral Med Oral Pathol</source>
          <year>1964</year>
          <volume>18</volume>
          <fpage>262</fpage>
          <lpage>71</lpage>
          <pub-id pub-id-type="doi">10.1016/0030-4220(64)90436-0</pub-id>
          <pub-id pub-id-type="pmid">14176614</pub-id>
        </element-citation>
      </ref>
      <ref id="CR7">
        <label>7.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zegarelli</surname>
              <given-names>DJ</given-names>
            </name>
            <name>
              <surname>Rankow</surname>
              <given-names>RM</given-names>
            </name>
            <name>
              <surname>Zegarelli</surname>
              <given-names>EV</given-names>
            </name>
          </person-group>
          <article-title>A large dental granuloma (? inflammatory pseudotumor) with unusual features: report of case</article-title>
          <source>J Am Dent Assoc</source>
          <year>1974</year>
          <volume>89</volume>
          <issue>4</issue>
          <fpage>891</fpage>
          <lpage>4</lpage>
          <pub-id pub-id-type="doi">10.14219/jada.archive.1974.0517</pub-id>
          <pub-id pub-id-type="pmid">4529462</pub-id>
        </element-citation>
      </ref>
      <ref id="CR8">
        <label>8.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cook</surname>
              <given-names>JR</given-names>
            </name>
            <name>
              <surname>Dehner</surname>
              <given-names>LP</given-names>
            </name>
            <name>
              <surname>Collins</surname>
              <given-names>MH</given-names>
            </name>
            <name>
              <surname>Ma</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Morris</surname>
              <given-names>SW</given-names>
            </name>
            <name>
              <surname>Coffin</surname>
              <given-names>CM</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Anaplastic lymphoma kinase (ALK) expression in the inflammatory myofibroblastic tumor: a comparative immunohistochemical study</article-title>
          <source>Am J Surg Pathol</source>
          <year>2001</year>
          <volume>25</volume>
          <issue>11</issue>
          <fpage>1364</fpage>
          <lpage>71</lpage>
          <pub-id pub-id-type="doi">10.1097/00000478-200111000-00003</pub-id>
          <pub-id pub-id-type="pmid">11684952</pub-id>
        </element-citation>
      </ref>
      <ref id="CR9">
        <label>9.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Inui</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Tagawa</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Mori</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Yoneda</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Nomura</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Fukumori</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Inflammatory pseudotumor in the submandibular region. Clinicopathologic study and review of the literature</article-title>
          <source>Oral Surg Oral Med Oral Pathol</source>
          <year>1993</year>
          <volume>76</volume>
          <issue>3</issue>
          <fpage>333</fpage>
          <lpage>7</lpage>
          <pub-id pub-id-type="doi">10.1016/0030-4220(93)90263-4</pub-id>
          <pub-id pub-id-type="pmid">8378046</pub-id>
        </element-citation>
      </ref>
      <ref id="CR10">
        <label>10.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Brooks</surname>
              <given-names>JK</given-names>
            </name>
            <name>
              <surname>Nikitakis</surname>
              <given-names>NG</given-names>
            </name>
            <name>
              <surname>Frankel</surname>
              <given-names>BF</given-names>
            </name>
            <name>
              <surname>Papadimitriou</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>Sauk</surname>
              <given-names>JJ</given-names>
            </name>
          </person-group>
          <article-title>Oral inflammatory myofibroblastic tumor demonstrating ALK, p53, MDM2, CDK4, pRb, and Ki-67 immunoreactivity in an elderly patient</article-title>
          <source>Oral Surg Oral Med Oral Pathol Oral Radiol Endod</source>
          <year>2005</year>
          <volume>99</volume>
          <issue>6</issue>
          <fpage>716</fpage>
          <lpage>26</lpage>
          <pub-id pub-id-type="doi">10.1016/j.tripleo.2004.11.023</pub-id>
          <pub-id pub-id-type="pmid">15897859</pub-id>
        </element-citation>
      </ref>
      <ref id="CR11">
        <label>11.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Poh</surname>
              <given-names>CF</given-names>
            </name>
            <name>
              <surname>Priddy</surname>
              <given-names>RW</given-names>
            </name>
            <name>
              <surname>Dahlman</surname>
              <given-names>DM</given-names>
            </name>
          </person-group>
          <article-title>Intramandibular inflammatory myofibroblastic tumor--a true neoplasm or reactive lesion?</article-title>
          <source>Oral Surg Oral Med Oral Pathol Oral Radiol Endod</source>
          <year>2005</year>
          <volume>100</volume>
          <issue>4</issue>
          <fpage>460</fpage>
          <lpage>6</lpage>
          <pub-id pub-id-type="doi">10.1016/j.tripleo.2004.07.005</pub-id>
          <pub-id pub-id-type="pmid">16182167</pub-id>
        </element-citation>
      </ref>
      <ref id="CR12">
        <label>12.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Oh</surname>
              <given-names>JH</given-names>
            </name>
            <name>
              <surname>Yim</surname>
              <given-names>JH</given-names>
            </name>
            <name>
              <surname>Yoon</surname>
              <given-names>BW</given-names>
            </name>
            <name>
              <surname>Choi</surname>
              <given-names>BJ</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>DW</given-names>
            </name>
            <name>
              <surname>Kwon</surname>
              <given-names>YD</given-names>
            </name>
          </person-group>
          <article-title>Inflammatory pseudotumor in the mandible</article-title>
          <source>J Craniofac Surg</source>
          <year>2008</year>
          <volume>19</volume>
          <issue>6</issue>
          <fpage>1552</fpage>
          <lpage>3</lpage>
          <pub-id pub-id-type="doi">10.1097/SCS.0b013e318188a2e9</pub-id>
          <pub-id pub-id-type="pmid">19098549</pub-id>
        </element-citation>
      </ref>
      <ref id="CR13">
        <label>13.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Johann</surname>
              <given-names>AC</given-names>
            </name>
            <name>
              <surname>Caldeira</surname>
              <given-names>PC</given-names>
            </name>
            <name>
              <surname>Abdo</surname>
              <given-names>EN</given-names>
            </name>
            <name>
              <surname>Sousa</surname>
              <given-names>SO</given-names>
            </name>
            <name>
              <surname>Aguiar</surname>
              <given-names>MC</given-names>
            </name>
            <name>
              <surname>Mesquita</surname>
              <given-names>RA</given-names>
            </name>
          </person-group>
          <article-title>Inflammatory myofibroblastic tumor of the alveolar mucosa of the mandible</article-title>
          <source>Minerva Stomatol</source>
          <year>2008</year>
          <volume>57</volume>
          <issue>1&#x2013;2</issue>
          <fpage>59</fpage>
          <lpage>63</lpage>
          <pub-id pub-id-type="pmid">18427372</pub-id>
        </element-citation>
      </ref>
      <ref id="CR14">
        <label>14.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Satomi</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Watanabe</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Matsubayashi</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Nagao</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Chiba</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>A successfully treated inflammatory myofibroblastic tumor of the mandible with long-term follow-up and review of the literature</article-title>
          <source>Med Mol Morphol</source>
          <year>2010</year>
          <volume>43</volume>
          <issue>3</issue>
          <fpage>185</fpage>
          <lpage>91</lpage>
          <pub-id pub-id-type="doi">10.1007/s00795-009-0483-6</pub-id>
          <pub-id pub-id-type="pmid">20857269</pub-id>
        </element-citation>
      </ref>
      <ref id="CR15">
        <label>15.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Date</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Yamagata</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Onizawa</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Yanagawa</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Karube</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Ishibashi</surname>
              <given-names>N</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Inflammatory pseudotumor: report of a case in the mandible</article-title>
          <source>Oral Maxillofac Surg</source>
          <year>2012</year>
          <volume>16</volume>
          <issue>1</issue>
          <fpage>65</fpage>
          <lpage>8</lpage>
          <pub-id pub-id-type="doi">10.1007/s10006-010-0250-9</pub-id>
          <pub-id pub-id-type="pmid">20978812</pub-id>
        </element-citation>
      </ref>
      <ref id="CR16">
        <label>16.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sasagawa</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Akai</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Itou</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Iizuka</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>Multiple intraosseous inflammatory myofibroblastic tumors presenting with an aggressive clinical course: case report</article-title>
          <source>Neurosurgery</source>
          <year>2011</year>
          <volume>69</volume>
          <issue>4</issue>
          <fpage>E1010</fpage>
          <lpage>5</lpage>
          <pub-id pub-id-type="doi">10.1227/NEU.0b013e318223b651</pub-id>
          <pub-id pub-id-type="pmid">21572361</pub-id>
        </element-citation>
      </ref>
      <ref id="CR17">
        <label>17.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gawande</surname>
              <given-names>PD</given-names>
            </name>
            <name>
              <surname>Sambhus</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Garde</surname>
              <given-names>JB</given-names>
            </name>
            <name>
              <surname>Halli</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Deshmukh</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Kulkarni</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Aggressive inflammatory pseudotumor of the mandible</article-title>
          <source>J Craniofac Surg</source>
          <year>2012</year>
          <volume>23</volume>
          <issue>4</issue>
          <fpage>1101</fpage>
          <lpage>3</lpage>
          <pub-id pub-id-type="doi">10.1097/SCS.0b013e318252da65</pub-id>
          <pub-id pub-id-type="pmid">22777474</pub-id>
        </element-citation>
      </ref>
      <ref id="CR18">
        <label>18.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sah</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Byatnal</surname>
              <given-names>AA</given-names>
            </name>
            <name>
              <surname>Rao</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Narayanaswamy</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Radhakrishnan</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Inflammatory myofibroblastic tumor: a rapidly growing soft tissue mass in the posterior mandible</article-title>
          <source>Head Neck Pathol</source>
          <year>2013</year>
          <volume>7</volume>
          <issue>4</issue>
          <fpage>393</fpage>
          <lpage>7</lpage>
          <pub-id pub-id-type="doi">10.1007/s12105-013-0474-8</pub-id>
          <pub-id pub-id-type="pmid">23843049</pub-id>
        </element-citation>
      </ref>
      <ref id="CR19">
        <label>19.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Stringer</surname>
              <given-names>DE</given-names>
            </name>
            <name>
              <surname>Allen</surname>
              <given-names>CN</given-names>
            </name>
            <name>
              <surname>Nguyen</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Tandon</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Intraosseous inflammatory myofibroblastic tumor in the mandible: a rare pathologic case report</article-title>
          <source>Case Rep Surg</source>
          <year>2014</year>
          <volume>2014</volume>
          <fpage>565478</fpage>
          <pub-id pub-id-type="pmid">25254136</pub-id>
        </element-citation>
      </ref>
      <ref id="CR20">
        <label>20.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bridge</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Kanamori</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Ma</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Pickering</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Hill</surname>
              <given-names>DA</given-names>
            </name>
            <name>
              <surname>Lydiatt</surname>
              <given-names>W</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Fusion of the ALK gene to the clathrin heavy chain gene, CLTC, in inflammatory myofibroblastic tumor</article-title>
          <source>Am J Pathol</source>
          <year>2001</year>
          <volume>159</volume>
          <issue>2</issue>
          <fpage>411</fpage>
          <lpage>5</lpage>
          <pub-id pub-id-type="doi">10.1016/S0002-9440(10)61711-7</pub-id>
          <pub-id pub-id-type="pmid">11485898</pub-id>
        </element-citation>
      </ref>
      <ref id="CR21">
        <label>21.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cools</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Wlodarska</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Somers</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Mentens</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Pedeutour</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Maes</surname>
              <given-names>B</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Identification of novel fusion partners of ALK, the anaplastic lymphoma kinase, in anaplastic large-cell lymphoma and inflammatory myofibroblastic tumor</article-title>
          <source>Genes Chromosomes Cancer</source>
          <year>2002</year>
          <volume>34</volume>
          <issue>4</issue>
          <fpage>354</fpage>
          <lpage>62</lpage>
          <pub-id pub-id-type="doi">10.1002/gcc.10033</pub-id>
          <pub-id pub-id-type="pmid">12112524</pub-id>
        </element-citation>
      </ref>
      <ref id="CR22">
        <label>22.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ma</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Hill</surname>
              <given-names>DA</given-names>
            </name>
            <name>
              <surname>Collins</surname>
              <given-names>MH</given-names>
            </name>
            <name>
              <surname>Morris</surname>
              <given-names>SW</given-names>
            </name>
            <name>
              <surname>Sumegi</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Zhou</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Fusion of ALK to the ran-binding protein 2 (RANBP2) gene in inflammatory myofibroblastic tumor</article-title>
          <source>Genes Chromosomes Cancer</source>
          <year>2003</year>
          <volume>37</volume>
          <issue>1</issue>
          <fpage>98</fpage>
          <lpage>105</lpage>
          <pub-id pub-id-type="doi">10.1002/gcc.10177</pub-id>
          <pub-id pub-id-type="pmid">12661011</pub-id>
        </element-citation>
      </ref>
      <ref id="CR23">
        <label>23.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Debiec-Rychter</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Marynen</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Hagemeijer</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Pauwels</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>ALK-ATIC fusion in urinary bladder inflammatory myofibroblastic tumor</article-title>
          <source>Genes Chromosomes Cancer</source>
          <year>2003</year>
          <volume>38</volume>
          <issue>2</issue>
          <fpage>187</fpage>
          <lpage>90</lpage>
          <pub-id pub-id-type="doi">10.1002/gcc.10267</pub-id>
          <pub-id pub-id-type="pmid">12939746</pub-id>
        </element-citation>
      </ref>
      <ref id="CR24">
        <label>24.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Panagopoulos</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Nilsson</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Domanski</surname>
              <given-names>HA</given-names>
            </name>
            <name>
              <surname>Isaksson</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Lindblom</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Mertens</surname>
              <given-names>F</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Fusion of the SEC31L1 and ALK genes in an inflammatory myofibroblastic tumor</article-title>
          <source>Int J Cancer</source>
          <year>2006</year>
          <volume>118</volume>
          <issue>5</issue>
          <fpage>1181</fpage>
          <lpage>6</lpage>
          <pub-id pub-id-type="doi">10.1002/ijc.21490</pub-id>
          <pub-id pub-id-type="pmid">16161041</pub-id>
        </element-citation>
      </ref>
      <ref id="CR25">
        <label>25.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Takeuchi</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Soda</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Togashi</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Sugawara</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Hatano</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Asaka</surname>
              <given-names>R</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Pulmonary inflammatory myofibroblastic tumor expressing a novel fusion, PPFIBP1-ALK: reappraisal of anti-ALK immunohistochemistry as a tool for novel ALK fusion identification</article-title>
          <source>Clin Cancer Res</source>
          <year>2011</year>
          <volume>17</volume>
          <issue>10</issue>
          <fpage>3341</fpage>
          <lpage>8</lpage>
          <pub-id pub-id-type="doi">10.1158/1078-0432.CCR-11-0063</pub-id>
          <pub-id pub-id-type="pmid">21430068</pub-id>
        </element-citation>
      </ref>
      <ref id="CR26">
        <label>26.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Subbiah</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>McMahon</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Patel</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Zinner</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Silva</surname>
              <given-names>EG</given-names>
            </name>
            <name>
              <surname>Elvin</surname>
              <given-names>JA</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>STUMP un&#x201C;stumped&#x201D;: anti-tumor response to anaplastic lymphoma kinase (ALK) inhibitor based targeted therapy in uterine inflammatory myofibroblastic tumor with myxoid features harboring DCTN1-ALK fusion</article-title>
          <source>J Hematol Oncol</source>
          <year>2015</year>
          <volume>8</volume>
          <fpage>66</fpage>
          <pub-id pub-id-type="doi">10.1186/s13045-015-0160-2</pub-id>
          <pub-id pub-id-type="pmid">26062823</pub-id>
        </element-citation>
      </ref>
      <ref id="CR27">
        <label>27.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Colleoni</surname>
              <given-names>GW</given-names>
            </name>
            <name>
              <surname>Bridge</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Garicochea</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Filippa</surname>
              <given-names>DA</given-names>
            </name>
            <name>
              <surname>Ladanyi</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>ATIC-ALK: a novel variant ALK gene fusion in anaplastic large cell lymphoma resulting from the recurrent cryptic chromosomal inversion, inv(2)(p23q35)</article-title>
          <source>Am J Pathol</source>
          <year>2000</year>
          <volume>156</volume>
          <issue>3</issue>
          <fpage>781</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="doi">10.1016/S0002-9440(10)64945-0</pub-id>
          <pub-id pub-id-type="pmid">10702393</pub-id>
        </element-citation>
      </ref>
      <ref id="CR28">
        <label>28.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wlodarska</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>De Wolf-Peeters</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Falini</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Verhoef</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Morris</surname>
              <given-names>SW</given-names>
            </name>
            <name>
              <surname>Hagemeijer</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The cryptic inv(2)(p23q35) defines a new molecular genetic subtype of ALK-positive anaplastic large-cell lymphoma</article-title>
          <source>Blood</source>
          <year>1998</year>
          <volume>92</volume>
          <issue>8</issue>
          <fpage>2688</fpage>
          <lpage>95</lpage>
          <pub-id pub-id-type="pmid">9763551</pub-id>
        </element-citation>
      </ref>
      <ref id="CR29">
        <label>29.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Owusu-Brackett</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Johanson</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Schindel</surname>
              <given-names>DT</given-names>
            </name>
            <name>
              <surname>Koduru</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Cope-Yokoyama</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>A novel ALK rearrangement in an inflammatory myofibroblastic tumor in a neonate</article-title>
          <source>Cancer Genet</source>
          <year>2013</year>
          <volume>206</volume>
          <issue>9&#x2013;10</issue>
          <fpage>353</fpage>
          <lpage>6</lpage>
          <pub-id pub-id-type="doi">10.1016/j.cancergen.2013.10.002</pub-id>
          <pub-id pub-id-type="pmid">24290361</pub-id>
        </element-citation>
      </ref>
      <ref id="CR30">
        <label>30.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Meis-Kindblom</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Kjellstrom</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Kindblom</surname>
              <given-names>LG</given-names>
            </name>
          </person-group>
          <article-title>Inflammatory fibrosarcoma: update, reappraisal, and perspective on its place in the spectrum of inflammatory myofibroblastic tumors</article-title>
          <source>Semin Diagn Pathol</source>
          <year>1998</year>
          <volume>15</volume>
          <issue>2</issue>
          <fpage>133</fpage>
          <lpage>43</lpage>
          <pub-id pub-id-type="pmid">9606804</pub-id>
        </element-citation>
      </ref>
      <ref id="CR31">
        <label>31.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Butrynski</surname>
              <given-names>JE</given-names>
            </name>
            <name>
              <surname>D&#x2019;Adamo</surname>
              <given-names>DR</given-names>
            </name>
            <name>
              <surname>Hornick</surname>
              <given-names>JL</given-names>
            </name>
            <name>
              <surname>Dal Cin</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Antonescu</surname>
              <given-names>CR</given-names>
            </name>
            <name>
              <surname>Jhanwar</surname>
              <given-names>SC</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Crizotinib in ALK-rearranged inflammatory myofibroblastic tumor</article-title>
          <source>N Eng J Med</source>
          <year>2010</year>
          <volume>363</volume>
          <issue>18</issue>
          <fpage>1727</fpage>
          <lpage>33</lpage>
          <pub-id pub-id-type="doi">10.1056/NEJMoa1007056</pub-id>
        </element-citation>
      </ref>
      <ref id="CR32">
        <label>32.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nishio</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Murakami</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Horiike</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Takahashi</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Hirai</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Suenaga</surname>
              <given-names>N</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Phase I study of ceritinib (LDK378) in Japanese patients with advanced, anaplastic lymphoma kinase-rearranged non-small-cell lung cancer or other tumors</article-title>
          <source>J Thorac Oncol</source>
          <year>2015</year>
          <volume>10</volume>
          <issue>7</issue>
          <fpage>1058</fpage>
          <lpage>66</lpage>
          <pub-id pub-id-type="doi">10.1097/JTO.0000000000000566</pub-id>
          <pub-id pub-id-type="pmid">26020125</pub-id>
        </element-citation>
      </ref>
      <ref id="CR33">
        <label>33.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jacob</surname>
              <given-names>SV</given-names>
            </name>
            <name>
              <surname>Reith</surname>
              <given-names>JD</given-names>
            </name>
            <name>
              <surname>Kojima</surname>
              <given-names>AY</given-names>
            </name>
            <name>
              <surname>Williams</surname>
              <given-names>WD</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Vila</surname>
              <given-names>DL</given-names>
            </name>
          </person-group>
          <article-title>An unusual case of systemic inflammatory myofibroblastic tumor with successful treatment with ALK-inhibitor</article-title>
          <source>Case Rep Pathol</source>
          <year>2014</year>
          <volume>2014</volume>
          <fpage>470340</fpage>
          <pub-id pub-id-type="pmid">25045570</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
